Royalty Pharma plc Stock Forecast
Royalty Pharma plc stock price ended at $28.11 on Thursday, after gaining 0.465%.
(Updated on Apr 25, 2024)
The Royalty Pharma plc stock price gained 0.465% on the last trading day (Thursday, 25th Apr 2024), rising from $27.98 to $28.11. During the last trading day the stock fluctuated 1.99% from a day low at $27.66 to a day high of $28.21. The price has risen in 6 of the last 10 days but is still down by -3.24% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 558 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $64.29 million.
The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -3.14% during the next 3 months and, with a 90% probability hold a price between $26.49 and $29.70 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
RPRX Signals & Forecast
A buy signal was issued from a pivot bottom point on Tuesday, April 16, 2024, and so far it has risen 2.37%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Royalty Pharma plc stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $29.32. On a fall, the stock will find some support from the short-term average at $27.91. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). The stock had a Golden Star Signal on Thursday, December 28, 2023 in the long-term chart.
Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.
Golden Star 12 Months
The stock had a Golden Star Signal on Thursday, December 28, 2023 in the long-term chart.Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.
Support, Risk & Stop-loss for Royalty Pharma plc stock
Royalty Pharma plc finds support from accumulated volume at $27.82 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.550 between high and low, or 1.99%. For the last week, the stock has had daily average volatility of 2.12%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (RPRX) For The Upcoming Trading Day Of Friday 26th
For the upcoming trading day on Friday, 26th we expect Royalty Pharma plc to open at $27.99, and during the day (based on 14 day Average True Range), to move between $27.50 and $28.72, which gives a possible trading interval of +/-$0.614 (+/-2.19%) up or down from last closing price. If Royalty Pharma plc takes out the full calculated possible swing range there will be an estimated 4.37% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $27.82 (1.03%) than the resistance at $29.05 (3.34%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Royalty Pharma plc stock A Buy?
Royalty Pharma plc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Current score: -2.026 Sell Candidate Unchanged
Predicted Opening Price for Royalty Pharma plc of Friday, April 26, 2024
Fair opening price April 26, 2024 | Current price |
---|---|
$27.99 ( 0.427%) | $28.11 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for RPRX
Fibonacci Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 28.54 | 1.53 % | |
R2 | 28.33 | 0.782 % | ||
R1 | 28.20 | 0.321 % | ||
Current price: | 28.11 | |||
Support | S1 | 27.78 | -1.17 % | |
S2 | 27.65 | -1.64 % | ||
S3 | 27.44 | -2.38 % |
Accumulated Volume Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 31.23 | 11.10 % | |
R2 | 30.19 | 7.40 % | ||
R1 | 29.05 | 3.34 % | ||
Current price | 28.11 | |||
Support | S1 | 27.82 | -1.03% | |
S2 | 27.71 | -1.42% | ||
S3 | 27.61 | -1.78% |
RPRX Dividend Payout History
# | Ex-Date | Pay Date | Amount | Yield | |
---|---|---|---|---|---|
1 | Apr 17, 2024 | May 16, 2024 | Jun 14, 2024 | $0.210 | 0.747% |
2 | Feb 15, 2024 | Feb 15, 2024 | Mar 15, 2024 | $0 | 0% |
3 | Oct 16, 2023 | Nov 16, 2023 | Dec 15, 2023 | $0.200 | 0.731% |
4 | Jul 17, 2023 | Aug 17, 2023 | Sep 15, 2023 | $0.200 | 0.711% |
5 | Apr 17, 2023 | May 18, 2023 | Jun 15, 2023 | $0.200 | 0.621% |
FAQ
Click here for our free guide on how to buy Royalty Pharma plc Stock.